Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck

Stopped Site decided not to move forward with trial. Study never opened to enrollment.

Conditions

• Squamous Cell Carcinoma of the Head and Neck

Interventions

• DRUG: Pembrolizumab
• DRUG: Epacadostat

Sponsor

University of Chicago